Blood bank

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Retrieved on: 
Giovedì, Aprile 4, 2024
Certification, Plasma, CE, GRFS, Risk, Arbovirus, Climate, RNA, GRF, Fever Dream, IVDR, Chikungunya, Death, Dengue virus, MCE, Blood bank, NAT, Vertically transmitted infection, Medical device

These are the four most significant arboviruses of concern, all spread through mosquito vectors.

Key Points: 
  • These are the four most significant arboviruses of concern, all spread through mosquito vectors.
  • With the dengue virus alone, there were more than 5 million cases and 5,000 deaths reported globally in 2023.1
    Further strengthening the Grifols Procleix portfolio for blood donor screening, the Procleix ArboPlex Assay uses plasma or serum samples to detect arboviral RNA.
  • Blood banks and collection centers could decide that deferrals are unnecessary if donors were tested and found negative using the Procleix ArboPlex Assay.
  • “With its 4-in-1 arbovirus test feature, the Grifols Procleix ArboPlex Assay has the ability to speed up and overall improve donor screening laboratory efficiency,” said Antonio Martínez, president of Grifols Diagnostic Business Unit.

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - COVID-19 Impact, Regions of Market Influence and What to Watch For Long-Term - ResearchAndMarkets.com

Retrieved on: 
Mercoledì, Dicembre 27, 2023
Infectious Diseases, Biotechnology, Health, COVID-19, Infection, Histology, Government, Research, Market, Test management, Size, Projection, Point, Point of care, Blood bank, IVD, Medical device

The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.
  • The 16th edition of The Worldwide Market for In Vitro Diagnostic Tests is based on vendor reporting, interviews, vendor activities, and more on a global scale.
  • The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry.
  • The 16th edition of the Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.

Boekel Scientific Introduces New Centrifuge Product Line

Retrieved on: 
Lunedì, Agosto 21, 2023
Centrifugation, Catalog, Blood bank, Research, Multimedia, STAT, LED, Steam, Laboratory, Water, Physics, VDC, Longevity, Compressed air

FEASTERVILLE-TREVOSE, Pa., Aug. 21, 2023 /PRNewswire/ -- Boekel Scientific introduces a new product line that consists of 4 families of centrifuges : economy, general purpose, STAT, and Blood Bank .

Key Points: 
  • FEASTERVILLE-TREVOSE, Pa., Aug. 21, 2023 /PRNewswire/ -- Boekel Scientific introduces a new product line that consists of 4 families of centrifuges : economy, general purpose, STAT, and Blood Bank .
  • Boekel Scientific, renowned for its storied history within the labware and laboratory apparatus manufacturing field, is well versed in centrifugation.
  • This new line of centrifuges combine modern technologies such as LED light indicators and brushless motors with the trusted Boekel Scientific quality and durability known for generations.
  • The Boekel Scientific centrifuges are all proudly made in the USA, with design, manufacturing, and product support residing in Pennsylvania.

Responding to Need for Blood, a San Diego Blood Drive will be Held on Monday, March 20th from 9:00am to 2:30pm at Better Business Bureau, 4747 Viewridge Ave., San Diego

Retrieved on: 
Martedì, Marzo 7, 2023
BBB, Pacific Southwest, SAN, Blood, Trauma, Small business, Better Business Bureau, Singapore Cord Blood Bank, Marketing, Blood bank, Medical device, Hospital

SAN DIEGO, March 7, 2023 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units. A single donation can help save up to three lives. As Southern California continues to grow, the need to expand blood collections is essential. Every donation saves lives.

Key Points: 
  • SAN DIEGO, March 7, 2023 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units.
  • "We are proud to collaborate with the San Diego Blood Bank in encouraging people to donate."
  • "We are grateful for the opportunity to positively impact our community by partnering with the San Diego Blood Bank to support this donation drive."
  • We're proud to support the life-saving donation drive and partner with fantastic organizations like the San Diego Blood Bank," says Christine Daniels, vice president of marketing, Mulligan Funding .

PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 2022

Retrieved on: 
Venerdì, Dicembre 9, 2022
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Memory, Peptide, Melanoma, Blood bank, PBMC, HLA-A2, B cell, Antigen, Large-cell lung carcinoma, NK, Poster, MUC1, Patient, NY-ESO-1, PDC, Lung cancer, Hlas, GMP, Non-small-cell lung carcinoma, PD-1, RECIST, White blood cell, Safety, Cancer, Dendritic cell, ESMO, Human, RNA transfection, LOQ, Clinical trial, Growth, Bioreactor, MAGE, EFS, Pembrolizumab, Mutation, Pharmaceutical industry, Vaccine, NSCLC

The preliminary data was presented today at a poster display session at the ESMO Immuno-Oncology Congress 2022 (ESMO-IO) in Geneva (Switzerland).

Key Points: 
  • The preliminary data was presented today at a poster display session at the ESMO Immuno-Oncology Congress 2022 (ESMO-IO) in Geneva (Switzerland).
  • The objectives of the phase I/II trial (PDC-LUNG-101) are to assess the safety, tolerability, immunogenicity and preliminary clinical activity of the drug candidate PDC*lung01, associated or not with anti-PD-1 treatment in NSCLC patients.
  • It is administered weekly by a subcutaneous and intravenous route, in six consecutive doses.
  • Safety and clinical activity of the product were presented at ESMO 2022 in September 2022 in Paris (France).

Doctors at Manipal Hospitals, Delhi successfully treats 6-year-old Iraqi girl for rare brain disease

Retrieved on: 
Mercoledì, Novembre 30, 2022
Hospital, Incidence, Skin, Scalp, Weakness, Ministry, Brain, Bed, Patient, NABL, Disease, Manipal Hospitals, Private company limited by shares, NABH, City, Bangalore, Vascular malformation, Family, Moyamoya disease, Stroke, Artery, ER, Acquisition, Blood bank, Health insurance, Health

NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.

Key Points: 
  • NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.
  • But, with the support from the Iraqi Ministry of Health, the family brought the little girl to India.
  • She was initially referred because of suspicion of a vascular malformation in her brain, but on further investigation, it was revealed that she was suffering from a rare condition called MoyaMoya Disease.
  • MoyaMoya Disease is a rare disease where the arteries supplying blood to the brain start to shrink.

Doctors at Manipal Hospitals, Delhi successfully treats 6-year-old Iraqi girl for rare brain disease

Retrieved on: 
Mercoledì, Novembre 30, 2022
Hospital, Incidence, Skin, Scalp, Weakness, Ministry, Brain, Bed, Patient, NABL, Disease, Manipal Hospitals, Private company limited by shares, NABH, City, Bangalore, Vascular malformation, Family, Moyamoya disease, Stroke, Artery, ER, Acquisition, Blood bank, Health insurance, Health

NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.

Key Points: 
  • NEW DELHI, Nov. 30, 2022 /PRNewswire/ --In a rare incidence, doctors at Manipal Hospitals, Delhi, successfully performed a special cerebral revascularization surgery on a 6-year-old girl from Iraq.
  • But, with the support from the Iraqi Ministry of Health, the family brought the little girl to India.
  • She was initially referred because of suspicion of a vascular malformation in her brain, but on further investigation, it was revealed that she was suffering from a rare condition called MoyaMoya Disease.
  • MoyaMoya Disease is a rare disease where the arteries supplying blood to the brain start to shrink.

Worldwide In Vitro Diagnostic Tests Market Report 2022 with Profiles of 200+ Companies - Financial Results, Product Launches, Company History and Strategic Plans - ResearchAndMarkets.com

Retrieved on: 
Martedì, Novembre 22, 2022
Health, Biotechnology, Infection, Non-functional testing, Blood bank, Government, Point of care, Projection, Histology, Size, Research, IVD, Financial result, Market, NYSE Arca Major Market Index, Medical device, Speciality chemicals, Retail, Coagulation, Hematology, Immunoassay

The 15th edition of The Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.

Key Points: 
  • The 15th edition of The Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.
  • The full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostic Tests the most trusted report by top companies in the industry.
  • The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests reflects the international scope of the in vitro diagnostics market size.
  • The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market.

PDC*line Pharma Presents First Clinical Results From Phase I/II trial With PDC*lung01 at ESMO 2022

Retrieved on: 
Martedì, Settembre 13, 2022
Research, Infectious Diseases, Clinical Trials, Stem Cells, Biotechnology, Other Health, Health, Science, Oncology, MUC1, Safety, Memory, Blood bank, RNA transfection, Bioreactor, Hlas, Hope, Data monitoring committee, KU Leuven, Population, European Society for Medical Oncology, Growth, Progression-free survival, NY-ESO-1, Melanoma, MAGE, Lung cancer, Patient, Degenerative disease, RECIST, CEO, Dendritic cell, Technology, Oncology, DLT, Large-cell lung carcinoma, SAE, PDC, EFS, PD-L1, PD-1, Mutation, Cancer, PBMC, GMP, B cell, Non-small-cell lung carcinoma, ESMO, Pharmaceutical industry, Vaccine, A2, NSCLC, A1

The preliminary data was presented today at a poster discussion session at the 2022 European Society for Medical Oncology (ESMO) Annual Meeting.

Key Points: 
  • The preliminary data was presented today at a poster discussion session at the 2022 European Society for Medical Oncology (ESMO) Annual Meeting.
  • The objectives of the phase I/II trial (PDC-LUNG-101) are to assess the safety, tolerability, immunogenicity and preliminary clinical activity of the drug candidate PDC*lung01, associated with, or not, anti-PD-1 treatment in NSCLC patients.
  • Results are reported on the first three cohorts that have been completed (A1/A2/B1).
  • With preliminary clinical data now available from patients of the first three enrolled cohorts, it is encouraging to see PDC*lung01 as safe, immunogenic and to have signs of clinical efficacy.

TerraPro Solutions, Better Business Bureau (BBB) Serving the Pacific Southwest, and Mulligan Funding, Team Up with San Diego Blood Bank for Life-Saving Donation Drive

Retrieved on: 
Mercoledì, Agosto 17, 2022
Wind, Organic, CEO, Pacific Ocean, Better Business Bureau, GWS, Trauma, Compliance, Blood, BBB, Marketing, Patient, Instagram, Small business, Twitter, SAN, Acquisition, International Association, Singapore Cord Blood Bank, Blood bank, Health, LinkedIn, U.S. Army Community Relations, Hospital, Pacific Southwest

SAN DIEGO, Aug. 17, 2022 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units. A single donation can help save up to three lives. As Southern California continues to grow, the need to expand blood collections in the region is critical. Every donation saves lives.

Key Points: 
  • The San Diego Blood Drive will be held on Friday, September 9th, from 10:00am to 4:00pm at the Better Business Bureau, 4747 Viewridge Ave., San Diego, CA 92123.
  • SAN DIEGO, Aug. 17, 2022 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units.
  • "We are extremely grateful that TerraPro Solutions, BBB Pacific Southwest's San Diego Campus and Mulligan Funding have joined forces to host a life-saving blood drive."
  • San Diego Blood Bank is a 501(c)(3) nonprofit organization also operating as Southern California Blood Bank.